1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Meningococcal vaccine
Trade Name:
Menveo
Manufacturer/Distributor:
Novartis Vaccines and Diagnostics
Classification:
Vaccine
ATC Class:
J07AH08 - meningococcus, tetravalent purified polysaccharides antigen conjugated
Status:
active
Notice of Compliance (yyyy/mm/dd):
2010/05/21
Date Marketed in Canada (yyyy/mm/dd):
2010/07/14
Presentation:
Powder and solution for injection - contains meningococcal groups A, C, W-135 and Y. DIN: 02347393
Comments:
For active immunization of adolescents (aged 11-18 years) and adults (aged 19-55 years) to prevent disease caused by Neiserria meningitidis serogroups A, C, W-135 and Y.
Back to:
Drug Product Listings 
